Pathological Tau Tangles Localize to Focal Cortical Dysplasia in Older Patients
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: Purpose: Reactivation of neurodevelopmental processes may contribute to neurodegeneration. For example, the proteins cyclin dependent kinase 5 (cdk5) and glycogen synthase kinase 3 beta (GSK3β), which are essential to normal cortical development, can hyperphosphorylate tau and might contribute to the pathogenesis of Alzheimer's disease. Focal cortical dysplasia (FCD) is an important neurodevelopmental cause of refractory human epilepsy within which dysplastic neurons exhibit increased immunoreactivity for cdk5 and GSK3β as well as neurofilamentous accumulations. We therefore hypothesized that the developmentally abnormal cortex of FCD might be more susceptible to tau‐mediated neurodegeneration than adjacent histologically normal cortex. Materials and Methods: We examined a series of 15 cases of FCD, spanning a wide age range, for β‐amyloid, pathologically phosphorylated tau and neurofibrillary tangles using silver staining, immunohistochemistry for tau, AT8, RD3, RD4 and two‐dimensional cell counting. Results:β‐amyloid plaques, aberrantly phosphorylated tau and neurofibrillary tangles are only found in older patients. The hyperphosphorylated tau tangles are confined to dysplastic neurons. Immunoreactivity for 3‐ and 4‐repeat tau was again only detected within regions of FCD in older patients. With increasing age, the dysplastic cortex became hypocellular and a higher proportion of dysplastic neurons exhibited pathological tau phosphorylation. Conclusions: In older patients, FCD appears more susceptible to formation of pathologically phosphorylated tau neurofibrillary tangles than adjacent histologically normal cortex. Our results suggest a novel convergence of pathological neurodevelopment with pathological age‐related neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular pathways to neurodegeneration
Bossy-Wetzel, E., Schwarzenbacher, R., & Lipton, S. A. (2004) · Nature Medicine · doi:10.1038/nm1067 · Cited by 740
Chae, T., Kwon, Y. T., Bronson, R., Dikkes, P., Li, E., & Tsai, L.-H. (1997) · Neuron · doi:10.1016/s0896-6273(01)80044-1 · Cited by 715 · cited 1×
“Indeed the p35 -/- mouse brain is not dissimilar in appearance to that of human FCD with gross cortical mislamination and large grotesque neurons placed in the superficial cortex (Chae et al., 1997), although in the p35 knockout mouse the cortical abnormalities affect the whole cortex.”
BackgroundThe Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation
Plattner, F., Angelo, M., & Giese, K. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603469200 · Cited by 340 · cited 3×
“This finding has remained somewhat controversial and recently it has been suggested that the main function of cdk5 in Alzheimer’s disease might be to enable GSK3β to hyperphosphorylate tau (Plattner et al., 2006).”
BackgroundInfluentialFischer, A., Sananbenesi, F., Pang, P. T., Lu, B., & Tsai, L.-H. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.033 · Cited by 277
Abnormal expression of cdk5 in focal cortical dysplasia in humans.
Sisodiya, S. M., Thom, M., Lin, W.-R., Bajaj, N. P. S., Cross, J. H., & Harding, B. N. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00520-7 · Cited by 22 · cited 2×
“Intriguingly, dysplastic neurons in FCD exhibit increased immunoreactivity for GSK3β (Cotter et al., 1999), aggregates of cdk5 (Sisodiya et al., 2002) and abnormal neurofilamentous inclusions (Duong et al., 1994).”
BackgroundSelf-citation
Cited by
Sen, A., Jette, N., Husain, M., & Sander, J. W. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33064-8 · Cited by 369
Self-citationInflammation in epilepsy: Clinical observations
Aronica, E., & Crino, P. B. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03033.x · Cited by 306
“In addition, neurodegenerative changes are observed in older patients with FCD (Sen et al., 2007).”
BackgroundCognition and dementia in older patients with epilepsy
Sen, A., Capelli, V., & Husain, M. (2018) · Brain · doi:10.1093/brain/awy022 · Cited by 280
Self-citationAnalyzing dendritic spine pathology in Alzheimer’s disease: Problems and opportunities
Dorostkar, M. M., Zou, C., Blazquez-Llorca, L., & Herms, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1449-5 · Cited by 235
“The deposition of hyperphosphorylated tau protein in neurons may be secondary to several different types of insults, such as epilepsy [134, 227], chronic traumatic brain injury [71], focal cortical dysplasia [174] or Niemann–Pick disease type C [117, 187].”
BackgroundDendritic Spine Pathology in Neurodegenerative Diseases
Herms, J., & Dorostkar, M. M. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044216 · Cited by 201
Metadata
- Authors
- Sen, A., Thom, M., Martinian, L., Harding, B., Cross, J. H., Nikolic, M., & Sisodiya, S. M.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2007-04-18
- Volume
- 48
- Issue
- 8
- Pages
- 1447-1454
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1900267874
- Cited by
- 70
- References
- 5
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathological Tau Tangles Localize to Focal Cortical Dysplasia in Older Patients. https://app.cochat.ai/papers/10.1111/j.1528-1167.2007.01107.x
- The paper
- Sen, A., Thom, M., Martinian, L., Harding, B., Cross, J. H., Nikolic, M., & Sisodiya, S. M. (2007). Pathological Tau Tangles Localize to Focal Cortical Dysplasia in Older Patients. Epilepsia. https://doi.org/10.1111/j.1528-1167.2007.01107.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.